• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
Yu Ping, Zou Chun-bo. Research advances on the role of microinflammatory state in vascular calcification in chronic kidney disease[J]. Journal of Clinical Nephrology, 2022, 22(9): 783-787. DOI: 10.3969/j.issn.1671-2390.2022.09.014
Citation: Yu Ping, Zou Chun-bo. Research advances on the role of microinflammatory state in vascular calcification in chronic kidney disease[J]. Journal of Clinical Nephrology, 2022, 22(9): 783-787. DOI: 10.3969/j.issn.1671-2390.2022.09.014
shu

Research advances on the role of microinflammatory state in vascular calcification in chronic kidney disease

  • 1 Graduate School, Dalian Medical University, Dalian 116044, China;

  • 2 Department of Nephrology, People's Hospital, Taizhou 225300, China

More Information
  • Received Date: November 11, 2021
  • Available Online: May 11, 2023
  • Published Date: September 27, 2022
    Graphical Abstract
    • Abstract
  • The annual incidence of chronic kidney disease(CKD) is rising rapidly in China. It causes a high economic burden on health system. Vascular calcification(VC) is one of the major causes of cardiovascular adverse events in CKD patients. The formation mechanism of VC has not been completely elucidated. Microinflammatory state is closely correlated with the formation of VC. The activation of monocyte phagocyte system, the releases of tumor necrosis factor α, interleukin, C-reactive protein and ratio of inflammatory parameters may participate in the occurrence and development of VC.
    • FullText(HTML)
    • References (51)
  • [1]
    Forbes A, Gallagher H.Chronic kidney disease in adults:assessment and management[J].Clin Med (Lond), 2020, 20(2):128-132.DOI: 10.7861/clinmed.cg.20.2
    [2]
    Hill NR, Fatoba ST, Oke JL, et al.Global prevalence of chronic kidney disease-A systematic review and meta-analysis[J/OL].PLoS One, 2016, 11(7):e0158765.DOI: 10.1371/journal.pone.0158765.
    [3]
    Grams ME, Coresh J, Segev DL, et al.Vascular disease, ESRD, and death:interpreting competing risk analyses[J].Clin J Am Soc Nephrol, 2012, 7(10):1606-1614.DOI: 10.2215/CJN.03460412.
    [4]
    Chen NX, Moe SM.Vascular calcification:pathophysiology and risk factors[J].Curr Hypertens Rep, 2012, 14(3):228-237.DOI: 10.1007/s11906-012-0265-8.
    [5]
    Campean V, Neureiter D, Varga I, et al.Atherosclerosis and vascular calcification in chronic renal failure[J].Kidney Blood Press Res, 2005, 28(5/6):280-289.DOI: 10.1159/000090182.
    [6]
    Rysz J, Franczyk B, Ławiński J, et al.Oxidative stress in ESRD patients on dialysis and the risk of cardiovascular diseases[J].Antioxidants (Basel), 2020, 9(11):1079.DOI: 10.3390/antiox9111079.
    [7]
    Kyriakidis NC, Cobo G, Dai L, et al.Role of uremic toxins in early vascular ageing and calcification[J].Toxins, 2021, 13(1):26.DOI: 10.3390/toxins13010026.
    [8]
    Ha CM, Park S, Choi YK, et al.Activation of Nrf2 by dimethyl fumarate improves vascular calcification[J].Vasc Pharmacol, 2014, 63(1):29-36.DOI: 10.1016/j.vph.2014.06.007.
    [9]
    Bogner JR.C-reaktives Protein (CRP):Serie Laborparameter, Folge 1[C-reactive protein].MMW Fortschr Med, 2021, 163(5):52-53.DOI: 10.1007/s15006-020-9504-0.
    [10]
    Jun JE, Lee YB, Lee SE, et al.Elevated serum uric acid predicts the development of moderate coronary artery calcification independent of conventional cardiovascular risk factors[J].Atherosclerosis, 2018, 272:233-239.DOI: 10.1016/j.atherosclerosis.2018.02.014.
    [11]
    薛骏, 杨海春, 李铭新等.炎症在尿毒症血管病变中的作用及其机制[J].中华肾脏病杂志, 2001(6):404-407.DOI: 10.3760/j.issn:1001-7097.2001.06.011.

    Xue J, Yang HC, Li MX, et al.Role of inflammation in the vascular lesions of uremic patients and its mechanism[J].Chin J Nephrol, 2001(6):404-407.DOI: 10.3760/j.issn:1001-7097.2001.06.011.
    [12]
    Cheng SP, Liu CL, Liu TP, et al.Association between parathyroid hormone levels and inflammatory markers among US adults[J].Mediat Inflamm, 2014, 2014:709024.DOI: 10.1155/2014/709024.
    [13]
    Ceneri N, Zhao LN, Young BD, et al.Rac2 modulates atherosclerotic calcification by regulating macrophage interleukin-1β production[J].Arterioscler Thromb Vasc Biol, 2017, 37(2):328-340.DOI: 10.1161/ATVBAHA.116.308507.
    [14]
    Dellegrottaglie S, Sanz J, Rajagopalan S.Molecular determinants of vascular calcification:a bench to bedside view[J].Curr Mol Med, 2006, 6(5):515-524.DOI: 10.2174/156652406778018653.
    [15]
    Tintut Y, Patel J, Parhami F, et al.Tumor necrosis factor-α promotes in vitro calcification of vascular cells via the cAMP pathway[J].Circulation, 2000, 102(21):2636-2642.DOI: 10.1161/01.cir.102.21.2636.
    [16]
    Boraschi D, Lucchesi D, Hainzl S, et al.IL-37:a new antiinflammatory cytokine of the IL-1 family[J].Eur Cytokine Netw, 2011, 22(3):127-147.DOI: 10.1684/ecn.2011.0288.
    [17]
    吉庆伟.白介素-37b与动脉粥样硬化的基础与临床研究进展[J].中国临床新医学, 2019, 12(5):474-477.DOI: 10.3969/j.issn.1674-3806.2019.05.02.

    Ji QW.IL-37b and atherosclerosis:from bench to bedside[J].Chin J New Clin Med, 2019, 12(5):474-477.DOI: 10.3969/j.issn.1674-3806.2019.05.02.
    [18]
    Chai M, Ji QW, Zhang HT, et al.The protective effect of interleukin-37 on vascular calcification and atherosclerosis in apolipoprotein E-deficient mice with diabetes[J].J Interferon Cytokine Res, 2015, 35(7):530-539.DOI: 10.1089/jir.2014.0212.
    [19]
    Nold MF, Nold-Petry CA, Zepp JA, et al.IL-37 is a fundamental inhibitor of innate immunity[J].Nat Immunol, 2010, 11(11):1014-1022.DOI: 10.1038/ni.1944.
    [20]
    Chai M, Zhang HT, Zhou YJ, et al.Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification[J].J Geriatr Cardiol, 2017, 14(5):285-291.DOI: 10.11909/j.issn.1671-5411.2017.05.013.
    [21]
    Chai M, Zhang HT, Zhou YJ, et al.Elevated IL-37 levels in the plasma of patients with severe coronary artery calcification[J].J Geriatr Cardiol, 2017, 14(5):285-291.DOI: 10.11909/j.issn.1671-5411.2017.05.013.
    [22]
    Zhou PT, Li QQ, Su SW, et al.Interleukin 37 suppresses M1 macrophage polarization through inhibition of the Notch1 and nuclear factor kappa B pathways[J].Front Cell Dev Biol, 2020, 8:56.DOI: 10.3389/fcell.2020.00056.
    [23]
    Rudloff I, Cho SX, Lao JC, et al.Monocytes and dendritic cells are the primary sources of interleukin 37 in human immune cells[J].J Leukoc Biol, 2017, 101(4):901-911.DOI: 10.1189/jlb.3MA0616-287R.
    [24]
    Liu J, Lin J, He S, et al.Transgenic overexpression of IL-37 protects against atherosclerosis and strengthens plaque stability[J].Cell Physiol Biochem, 2018, 45(3):1034-1050.DOI: 10.1159/000487344.
    [25]
    Miah M, Goh I, Haniffa M.Prenatal development and function of human mononuclear phagocytes[J].Front Cell Dev Biol, 2021, 9:649937.DOI: 10.3389/fcell.2021.649937.
    [26]
    Burgmaier M, Milzi A, Dettori R, et al.Co-localization of plaque macrophages with calcification is associated with a more vulnerable plaque phenotype and a greater calcification burden in coronary target segments as determined by OCT[J/OL].PLoS One, 2018, 13(10):e0205984.DOI: 10.1371/journal.pone.0205984.
    [27]
    Yoshida H, Yokoyama K, Yaginuma T, et al.Difference in coronary artery intima and media calcification in autopsied patients with chronic kidney disease[J].Clinical nephrology, 2011, 75(1):1-7.DOI: 10.2379/CN106401.
    [28]
    Ikeda K, Souma YK, Akakabe Y, et al.Macrophages play a unique role in the plaque calcification by enhancing the osteogenic signals exerted by vascular smooth muscle cells[J].Biochem Biophys Res Commun, 2012, 425(1):39-44.DOI: 10.1016/j.bbrc.2012.07.045.
    [29]
    Li RS, Mittelstein D, Lee J, et al.A dynamic model of calcific nodule destabilization in response to monocyte-and oxidized lipidinduced matrix metalloproteinases[J].Am J Physiol Cell Physiol, 2012, 302(4):C658-C665.DOI: 10.1152/ajpcell.00313.2011.
    [30]
    Nadra I, Mason JC, Philippidis P, et al.Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways:a vicious cycle of inflammation and arterial calcification?[J].Circ Res, 2005, 96(12):1248-1256.DOI: 10.1161/01.RES.0000171451.88616.c2.
    [31]
    New SEP, Goettsch C, Aikawa M, et al.Macrophage-derived matrix vesicles:an alternative novel mechanism for microcalcification in atherosclerotic plaques[J].Circ Res, 2013, 113(1):72-77.DOI: 10.1161/CIRCRESAHA.113.301036.
    [32]
    Chistiakov DA, Myasoedova VA, Melnichenko AA, et al.Calcifying matrix vesicles and atherosclerosis[J].Biomed Res Int, 2017, 2017:7463590.DOI: 10.1155/2017/7463590.
    [33]
    Boyle WJ, Simonet WS, Lacey DL.Osteoclast differentiation and activation[J].Nature, 2003, 423(6937):337-342.DOI: 10.1038/nature01658.
    [34]
    Rogers MA, Aikawa M, Aikawa E.Macrophage heterogeneity complicates reversal of calcification in cardiovascular tissues[J].Circ Res, 2017, 121(1):5-7.DOI: 10.1161/CIRCRESAHA.117.311219.
    [35]
    Wang XR, Yuan L, Shi R, et al.Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease[J].Ren Fail, 2021, 43(1):1172-1179.DOI: 10.1080/0886022X.2021.1953529.
    [36]
    Kotani K.Neutrophil/lymphocyte ratio and the oxidative stress burden[J].Can J Cardiol, 2015, 31(3):365.e9.DOI: 10.1016/j.cjca.2014.11.026.
    [37]
    Taleb S.Inflammation in atherosclerosis[J].Arch Cardiovasc Dis, 2016, 109(12):708-715.DOI: 10.1016/j.acvd.2016.04.002.
    [38]
    Sato H, Takeuchi Y, Matsuda K, et al.Pre-dialysis neutrophillymphocyte ratio, a novel and strong short-term predictor of allcause mortality in patients with diabetic nephropathy:results from a single-center study[J].Ther Apher Dial, 2017, 21(4):370-377.DOI: 10.1111/1744-9987.12533.
    [39]
    Wang XQ, Fan XD, Ji SF, et al.Prognostic value of neutrophil to lymphocyte ratio in heart failure patients[J].Clin Chimica Acta, 2018, 485:44-49.DOI: 10.1016/j.cca.2018.06.021.
    [40]
    Turkmen K, Ozcicek F, Ozcicek A, et al.The relationship between neutrophil-to-lymphocyte ratio and vascular calcification in end-stage renal disease patients[J].Hemodial Int, 2014, 18(1):47-53.DOI: 10.1111/hdi.12065.
    [41]
    Turkmen K, Guney I, Yerlikaya FH, et al.The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients[J].Ren Fail, 2012, 34(2):155-159.DOI: 10.3109/0886022X.2011.641514.
    [42]
    Turkmen K, Erdur FM, Ozcicek F, et al.Platelet-tolymphocyte ratio better predicts inflammation than neutrophilto-lymphocyte ratio in end-stage renal disease patients[J].Hemodial Int, 2013, 17(3):391-396.DOI: 10.1111/hdi.12040.
    [43]
    王云丹, 蒋卫杰.hs-CRP、NLR、PLR与维持性血液透析患者心脏瓣膜钙化的相关性[J].临床肾脏病杂志, 2020, 20(2):109-113.DOI: 10.3969/j.issn.1671-2390.2020.02.004.

    Wang YD, Jiang WJ.Correlation of hs-CRP, NLR and PLR tocardiac valve calcification in maintenance hemodialysis patients[J].J Clin Nephrol, 2020, 20(2):109-113.DOI: 10.3969/j.issn.1671-2390.2020.02.004.
    [44]
    Zeng MR, Liu Y, Liu FY, et al.J-shaped association of plateletto-lymphocyte ratio with 5-year mortality among patients with chronic kidney disease in a prospective cohort study[J].Int Urol Nephrol, 2020, 52(10):1943-1957.DOI: 10.1007/s11255-020-02548-1.
    [45]
    Zhang JL, Lu XX, Wang SX, et al.High neutrophil-tolymphocyte ratio and platelet-to-lymphocyte ratio are associated with poor survival in patients with hemodialysis[J].Biomed Res Int, 2021, 2021:9958081.DOI: 10.1155/2021/9958081.
    [46]
    Libby P.Inflammation in atherosclerosis[J].Arterioscler Thromb Vasc Biol, 2012, 32(9):2045-2051.DOI: 10.1161/ATVBAHA.108.179705.
    [47]
    邢文秀, 任彩霞, 鹿恩邦, 等.中性粒细胞/淋巴细胞比值和血小板/淋巴细胞比值对腹膜透析患者腹主动脉钙化的评估价值[J].临床肾脏病杂志, 2021, 21(1):38-43.DOI: 10.3969/j.issn.1671-2390.w20-110.

    Xing WX, Ren CX, Lu EB, et al.Evaluations of neutrophil-tolymphocyte and platelet-to-lymphocyte ratios for abdominal aortic cal-cification in peritoneal dialysis patients[J].Journal of Clinical Nephrology, 2021, 21(1):38-43.DOI: 10.3969/j.issn.1671-2390.w20-110.
    [48]
    Ganjali S, Gotto Jr AM, Ruscica M, et al.Monocyte-to-HDLcholesterol ratio as a prognostic marker in cardiovascular diseases[J].J Cell Physiol, 2018, 233(12):9237-9246.DOI: 10.1002/jcp.27028.
    [49]
    Zhang MH, Wu SH, Xu S, et al.Impact of monocyte to highdensity lipoprotein ratio on the identification of prevalent coronary heart disease:insights from a general population[J].Postgrad Med, 2021, 133(7):822-829.DOI: 10.1080/00325481.2021.1957265.
    [50]
    吴美豪, 曹慧霞, 王丽姣, 等.单核细胞/高密度脂蛋白比值与慢性肾脏病疾病严重程度及预后的关系[J].中华肾脏病杂志, 2021, 37(7):567-575.DOI: 10.3760/cma.j.cn441217-20210202-00086.

    Wu MH, Cao HX, Wang LJ, et al.Relationship between monocyte/high-density lipoprotein ratio and severity and prognosis of chronic kidney disease[J].Chin J Nephrol, 2021, 37(7):567-575.DOI: 10.3760/cma.j.cn441217-20210202-00086.
    [51]
    Ozhan H, Aydin M, Yazici M, et al.Mean platelet volume in patients with non-alcoholic fatty liver disease[J].Platelets, 2010, 21(1):29-32.DOI: 10.3109/09537100903391023.
    • Related Articles

  • Cited by

    Periodical cited type(3)

    1. 何杭，刘旻，王笑薇，余康敏. 血管钙化对超声引导下经皮腔内血管成形干预动静脉瘘狭窄后通畅率的影响. 中国介入影像与治疗学. 2024(09): 540-544 .
    2. 韦阳，高改琴，闫晓鹏，杨敏. 血清Sortilin、TMAO与维持性血液透析患者炎症因子和腹主动脉钙化的关系研究. 国际检验医学杂志. 2024(23): 2856-2861 .
    3. 赖宇慧，张楚. 不同类型血管通路在维持性血液透析患者中的应用效果. 中外医学研究. 2023(31): 147-150 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML
    Article views (119) PDF downloads (163) Cited by(9)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Links

    Website Copyright © Wuhan Medical and Health Association Joint Office Editorial Department of Journal of Clinical Nephrology   备案号：鄂ICP备13011742号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return